Clinical Trials
- Hepatitis, HIV/AIDS, Immune System, Infectious Disease
Screening In Anticipation of Future Research
- Ages2 years - 17 years
- GenderBoth
- Leukemia
The PRIME Trial: PARP Inhibition in IDH Mutant Effectiveness Trial. A Phase II Study of Olaparib in Isocitrate Dehydrogenase (IDH) Mutant Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome
- Hepatitis, Liver
Digoxin In Alcohol Associated Hepatitis
- Ages21 years - 65 years
- GenderBoth
- HIV/AIDS, Immune System, Infectious Disease
Establish and Characterize an Acute HIV Infection Cohort in a High Risk Population
- Ages18 years and older
- GenderBoth
- Brain, Spinal Cord & Nervous System, HIV/AIDS, Infectious Disease, COVID-19 Inpatient, COVID-19 Outpatient
HIV Associated Reservoirs and Comorbidities (The HARC Plus Study)
- Kidney & Urinary Tract, HIV/AIDS
HOPE in Action Prospective Multicenter, Clinical Trial of Deceased HIVD+ Kidney Transplants for HIV+ Recipients
- Ages18 years and older
- GenderBoth
- HIV/AIDS
Mechanisms of HIV latency
- Ages18 years and older
- GenderBoth
- Addictive Behavior, HIV/AIDS, Infectious Disease
Impact of HIV Infection on Immunologic, Transcriptomic, and Metabolomic Signatures
- Ages18 years and older
- GenderBoth
- HIV/AIDS, Infectious Disease, Tobacco Addiction
A Smart Approach to Treating Tobacco Use Disorder in Persons Living With HIV (SMARTTT)
- Ages18 years and older
- GenderBoth
- Liver, HIV/AIDS, Infectious Disease
HOPE in Action Trial of HIV+ Deceased Donor Liver Transplants for HIV+ Recipients
- Ages18 years and older
- GenderBoth